XML 35 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A and B common stock
Common stock and Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings (accumulated deficit)
Retained earnings (accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2021     464,944          
Beginning balance at Dec. 31, 2021 $ 3,313,589     $ 3,317,255 $ (16,435) $ (27,965)   $ 40,734
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2023-08 [Member]              
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ (553,005)         (540,747)   (12,258)
Shares issued in connection with employee stock plans (in shares)     11,824          
Shares issued in connection with employee stock plans 81,768     81,768        
Issuance of common stock in connection with business combination (in shares)     113,617          
Issuance of common stock in connection with business combination 13,827,929     13,827,929        
Change in other comprehensive income (loss) (506,655)       (506,655)      
Share-based compensation 1,092,010     1,092,010        
Tax withholding related to vesting of restricted stock units (in shares)     (37)          
Tax withholding related to vesting of restricted stock units (4,735)     (4,735)        
Issuance of common stock in conjunction with the conversion of convertible of notes (in shares)     20          
Issuance of common stock in conjunction with the conversion of convertible notes $ 454     454        
Exercise of bond hedges in conjunction with the conversion of convertible notes (in shares)     (1,189)          
Issuance of common stock in connection with the exercise of common stock warrants (in shares) 10,881              
Ending balance (in shares) at Dec. 31, 2022     600,060          
Ending balance at Dec. 31, 2022 $ 17,251,355 $ 30,511   18,314,681 (523,090) (568,712) $ 30,511 28,476
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest (21,124)         9,772   (30,896)
Shares issued in connection with employee stock plans (in shares)     18,055          
Shares issued in connection with employee stock plans 130,433     130,433        
Repurchases of common stock (in shares)     (2,466)          
Repurchases of common stock (156,812)     (156,812)        
Issuance of common stock in connection with business combination (in shares)     172          
Issuance of common stock in connection with business combination 6,658     6,658        
Change in other comprehensive income (loss) 144,783       144,783      
Share-based compensation 1,307,032     1,307,032        
Ending balance (in shares) at Dec. 31, 2023     615,821          
Ending balance at Dec. 31, 2023 18,692,836     19,601,992 (378,307) (528,429)   (2,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 2,866,497         2,897,047   (30,550)
Shares issued in connection with employee stock plans (in shares)     20,799          
Shares issued in connection with employee stock plans 154,779     154,779        
Repurchases of common stock (in shares)     (16,944)          
Repurchases of common stock (1,170,339)     (1,170,339)        
Change in other comprehensive income (loss) (622,758)       (622,758)      
Share-based compensation 1,313,947     1,313,947        
Ending balance (in shares) at Dec. 31, 2024     619,676          
Ending balance at Dec. 31, 2024 $ 21,234,962     $ 19,900,379 $ (1,001,065) $ 2,368,618   $ (32,970)